{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T13:33:58Z","timestamp":1782567238010,"version":"3.54.5"},"reference-count":10,"publisher":"SMC Media","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Haemoptysis is the expectoration of blood originating from the respiratory tract and occurs secondary to infection, malignancy, bronchiectasis or vascular disease. Its severity varies from minimal blood-streaked sputum to life-threatening haemorrhage. Therefore, prompt evaluation of the cause of the haemoptysis and its severity, and timely management are crucial. Although there is still no effective therapy for haemoptysis apart from treating the cause, inhaled tranexamic acid (TXA) might have a potential role in controlling non-massive haemoptysis. Here, we present a case of non-massive haemoptysis in a COPD patient with bronchiectasis on rivaroxaban for atrial fibrillation who responded to inhaled TXA following a failed trial of the oral formulation.<\/jats:p>","DOI":"10.12890\/2020_001930","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T09:52:37Z","timestamp":1621936357000},"source":"Crossref","is-referenced-by-count":2,"title":["Inhaled Tranexamic Acid for Non-Massive Haemoptysis in a Rivaroxaban-Receiving Patient Not Responding to the Oral Form"],"prefix":"10.12890","volume":"7","author":[{"given":"Mugahid","family":"Eltahir","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Nabil","family":"Elshafei","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelnasser Elzouki","family":"Abdelnasser Elzouki","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar; Weill Cornell Medicine-Qatar, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10397","published-online":{"date-parts":[[2020,12,30]]},"reference":[{"key":"10.12890\/2020_001930_ref1","doi-asserted-by":"crossref","unstructured":"<li>Johnston H, Reisz G. Changing spectrum of hemoptysis: underlying causes in 148 patients undergoing diagnostic flexible fiberoptic bronchoscopy. <em>Arch Intern Med<\/em> 1989;<strong>149<\/strong>(7):1666\u20131668.<\/li>","DOI":"10.1001\/archinte.1989.00390070168029"},{"key":"10.12890\/2020_001930_ref2","unstructured":"<li>Unsal E, Koksal D, Cimen F, Taci Hoca N, Sipit T. Analysis of patients with hemoptysis in a reference hospital for chest diseases. <em>Tuberk Toraks<\/em> 2006;<strong>54<\/strong>(1):34\u201342.<\/li>"},{"key":"10.12890\/2020_001930_ref3","doi-asserted-by":"crossref","unstructured":"<li>Santiago S, Tobias J, Williams AJ. A reappraisal of the causes of hemoptysis. <em>Arch Intern Med<\/em> 1991;<strong>151<\/strong>(12):2449\u20132451. <\/li>","DOI":"10.1001\/archinte.1991.00400120087015"},{"key":"10.12890\/2020_001930_ref4","doi-asserted-by":"crossref","unstructured":"<li>Prasad R, Garg R, Singhal S, Srivastava P. Lessons from patients with hemoptysis attending a chest clinic in India. <em>Ann Thorac Med<\/em> 2009;<strong>4<\/strong>(1):10.<\/li>","DOI":"10.4103\/1817-1737.43062"},{"key":"10.12890\/2020_001930_ref5","doi-asserted-by":"crossref","unstructured":"<li>Ibrahim WH. Massive haemoptysis: the definition should be revised. <em>Eur Respir J<\/em> 2008;<strong>32<\/strong>(4):1131\u20131132.<\/li>","DOI":"10.1183\/09031936.00080108"},{"key":"10.12890\/2020_001930_ref6","doi-asserted-by":"crossref","unstructured":"<li>Wand O, Guber E, Guber A, Shochet GE, Israeli-Shani L, Shitrit D. Inhaled tranexamic acid for hemoptysis treatment: a randomized controlled trial.<em> Chest<\/em> 2018;<strong>154<\/strong>(6):1379\u20131384.<\/li>","DOI":"10.1016\/j.chest.2018.09.026"},{"key":"10.12890\/2020_001930_ref7","doi-asserted-by":"crossref","unstructured":"<li>Dhanani JA, Roberts J, Reade MC. Nebulized tranexamic acid therapy for hemoptysis associated with submassive pulmonary embolism. <em>J Aerosol Med Pulm Drug Deliv<\/em> 2020;<strong>33<\/strong>(1):12\u201314.<\/li>","DOI":"10.1089\/jamp.2019.1534"},{"key":"10.12890\/2020_001930_ref8","doi-asserted-by":"crossref","unstructured":"<li>Prutsky G, Domecq JP, Salazar CA, Accinelli R. Antifibrinolytic therapy to reduce haemoptysis from any cause. <em>Cochrane Database Syst Rev<\/em> 2012;(4):CD008711.<\/li>","DOI":"10.1002\/14651858.CD008711.pub2"},{"key":"10.12890\/2020_001930_ref9","doi-asserted-by":"crossref","unstructured":"<li>Zhao Y, Li F, Liu Y, Shi Y, Li Z, Cao G, et al. Comparison of efficiency of inhaled and intravenous corticosteroid on pregnant women with COPD and the effects on the expression of PCT and hs-CRP. <em>Exp Ther Med<\/em> 2018;<strong>15<\/strong>(6):4717\u20134722. <\/li>","DOI":"10.3892\/etm.2018.6011"},{"key":"10.12890\/2020_001930_ref10","doi-asserted-by":"crossref","unstructured":"<li>Trend S, von Ungern, Sternberg BS, Devadason SG, Schultz A, Everard ML. Current options in aerosolised drug therapy for children receiving respiratory support. <em>Anaesthesia<\/em> 2017;<strong>72<\/strong>(11):1388\u20131397. <\/li>","DOI":"10.1111\/anae.14011"}],"container-title":["European Journal of Case Reports in Internal Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/1930\/2506","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/1930\/2507","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/1930\/2507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T12:15:31Z","timestamp":1756469731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/view\/1930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,30]]},"references-count":10,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.12890\/2020_001930","relation":{"has-manifestation":[{"id-type":"other","id":"1-65-1930-g2506","asserted-by":"subject"},{"id-type":"other","id":"1-65-1930-g2507","asserted-by":"subject"}],"is-part-of":[{"id-type":"other","id":"1-65","asserted-by":"subject"}]},"ISSN":["2284-2594"],"issn-type":[{"value":"2284-2594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,30]]},"article-number":"21"}}